UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine
ISSN 2079-0325(p)
DOI 10.36927/2079-0325
Home » Archive of numbers » 2008 » Volume 16, issue 2 (55) » Possibilities of new generation's anticonvulsants in pharmacotherapy of epilepsy

Possibilities of new generation's anticonvulsants in pharmacotherapy of epilepsy

Authors

Type of Article

  • Scientific Article

In the Section

  • DIAGNOSIS AND TREATMENT OF NEUROLOGICAL DISORDERS
Index UDK:
  • 615. 213

Abstract

In the present paper a modern approaches to treatment of epilepsy have been looked. A main attention paid to possibilities of new generation’s anticonvulsants as an effective tools of monotherapy and add-on therapy of different clinical forms of this disease. Mechanisms of action and clinical efficacy of one of the most perspective new drug-anticonvulsant — topiramate (Epiramat) have been analyzed in details. Expediency of use of this drug in different treatment strategies of epilepsy in patients of different ages has been grounded.

Pages

  • 5-9

Year / Issue

Download PDF

References

  1. Belousova E., Vlasov P., Ermakov A. et al. Not to make a mistake in choosing. Expert consensus on comparative evaluation of antiepileptic drugs used in Russia // Bulletin of psychiatry. psychopharmacology. - 2005. - No. 2. - P. 133-136.
  2. Brody M. The course and rational therapy of epilepsy // International Neurological Journal. - 2005. - № 4. - С. 72-83.
  3. Vlasov P. N., Dubenko A. E. Effective antiepileptic therapy: remission or recovery? // Zdorov'ya Ukraina. - 2007. - № 11/1. - С. 43-45.
  4. Gecht A. B Milchakova L. E., Gusev E. I. Experience in the use of Topamax: clinical and pharmacoeconomic aspects // Journal of Neurol. psychiatr. - 2005. - Т. 107, № 12. - С. 40-44.
  5. Dziak L.A., Zenkov L.R., Kirichenko A.G. Epilepsy. - Kyiv: Book-plus, 2001. - 168 p.
  6. Dorofeeva M. Yu, Ermakov A. Yu, Belousova E. D. Effectiveness of topiramate (Topamax) in the treatment of resistant epilepsy in children // Journal of Neurol. psychiatr. - 2005. - Т. 105, № 11. - С. 21-23.
  7. Dubenko A. Е. Modern principles of epilepsy treatment // Intern. med. journal. - 1998. - № 1. - С. 69-72.
  8. Emelianova OI, Filonenko MA, Serdyuk EA Side effects of new generation antiepileptic drugs in children, pregnant women and elderly patients // Veterinary medicine. - 2006. - № 1-2. - P. 44-51.
  9. Zenkov L. R. Algorithms of drug selection in the treatment of focal epilepsy // Rus. med. journal. - 2004. - № 5. - С. 270-275.
  10. Kalinin V. V. New antiepileptic drug Topamax // Ibid. - 2002. - № 25. - С. 1179-1186.
  11. Kalinin V. V., Zheleznova E. V., Sokolova L. V. et al. Monotherapy of partial forms of epilepsy with Topamax // Journal of Neurol. psychiatr. - 2004. - Т. 104, № 7. - С. 35-38.
  12. Karlov V. A. Strategy and tactics of epilepsy therapy today // Ibid. - 2004. - Т. 104, № 8. - С. 28-34.
  13. Marzenkovsky I. A. Treatment of epilepsy // Zdorov'ya Ukrainy. - 2004. - № 8. - С. 38-39.
  14. Mukhin K. Y., Glukhova L. Y., Petrukhin A. S. et al. S. et al. Topamax in monotherapy of epilepsy // Journal of Neurol. psychiatr. - 2004. - Т. 104, № 8. - С. 35-40.
  15. Kharitonov V. I., Martynyuk V. Yu. Y. Efficacy and safety of topiramate in monotherapy for first-diagnosed epilepsy with partial seizures in comparison with carbamazepine and lamotrigine // Zdorov'ya Ukrainy. - 2007. - № 6/1. - С. 33.
  16. Kharchuk S.M., Kompaniets O.L. Epilepsy: treatment in Ukraine // Ukrainian Medical Newspaper. 2006 - No. 2 - P. 16.
  17. Shershever A. S., Lavrova S. A., Telegin A. V., et al. V. et al. Criteria for assessing the quality of treatment of symptomatic epilepsy with the drugs Keppra and Topamax // Journal of Neurol. psychiatr. - 2007. - Т. 107, № 7. - С. 15-19.
  18. Abou-Khalil B. Topiramat in the long-term management of refractory epilepsy // Epilepsia. — 2000. — V. 41, suppl. 1. — P. S72—S76.
  19. Armijo J. A., Herranz J. L. Rational combination therapy in epilepsy. II. Clinical and pharmacological aspects // Rev. Neurol. — 2007. — V. 45. — P. 163—173.
  20. Ben-Menachem E. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience // Epilepsia. — 1997. — V. 38, suppl. 1. — P. S28—S30.
  21. Ben-Menachem E. Weight issues for people with epilepsy — a review // Ibid. — 2007. — V. 48., suppl. 9. — P. S42—S45.
  22. Cross J. H. Topiramate, carbamazepine and valproate monotherapy in children with newly diagnosed epilepsy // Ibid. — 2001. — V. 42. — P. 87.
  23. Deckers C. L. P., Genton P., Sills G. J. et al. Current limitations of antiepileptic drugs: a conference review // Epilepsy Res. — 2003. — V. 53. — P. 1—17.
  24. French J., Kanner A. M., Bautista J. et al. Efficacy and tolerability of the new antiepileptic drugs. I: Treatment of new onset epilepsy. Report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society // Neurology. — 2004. — V. 62. — P. 1252—1264.
  25. Glauser T. Preliminary observations on topiramate in pediatric epilepsies // Epilepsia. — 1997. — V. 38, suppl. 1. — P. S37—S41.
  26. Guberman A. H., Besag F. M. C., Brodie M. J. et al. Lamotrigineassociated rash: risk/benefit considerations in adults and children // Ibid. — 1999. — V. 40. — P. 985—991.
  27. the Holmes G. Advances in disease modification: protecting immature brain from neuronal insults // Neuroscience in Action: from Clinical Dilemma to Therapeutic Breakthrough. — Conf. Abstr. — 22—23 March 2002, Hamburg, Germany. — Hamburg, 2002. — P. 50.
  28. Ketter T., Post R., Theodore W. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders // Neurology. — 1999. — V. 53, suppl. 2. — P. S53—S67.
  29. Kuzniecky R., Ho S., Pan J. et al. Modulation of cerebral GABA by topiramate, lamotrigine and gabapentin in healthy adults // Ibid. — 2002. — V. 58. — P. 368—372.
  30. Kwan P., Brodie M. J. Effectiveness of first antiepileptic drug // Epilepsia. — 2001. — V. 42. — P. 1255—1260.
  31. Landmark C. J. Targets for antiepileptic drugs in the synapse // Med. Sci. Monit. — 2007. — V. 13. — P. 1—7.
  32. Latini G., Verrotti A., Manco R. et al. Topiramate: its pharmacological properties and therapeutic efficacy in epilepsy // Mini Rev. Med. Chem. — 2008. — V. 8. — P. 10—23.
  33. Lyseng-Williamson K. A., Yang L. P. Topiramate: a review of its use in the treatment of epilepsy // Drugs. — 2007. — V. 67. — P. 2231—2256.
  34. Marson A. G., Appleton R., Baker G. A. et al. A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial // Health Technol. Assess. — 2007. — V. 11. — P. 1—134.
  35. Penry J. K., Dean J. C., Riela A. R. Juvenile myoclonic epilepsy: long-term response to therapy // Epilepsia. — 1989. — V. 30, suppl. 4. — P. S19—S32.
  36. Privitera M. D. Topiramate: a new antiepileptic drug // Ann. Pharmacother. — 1997. — V. 31. — P. 1164—1173.
  37. Sachdeo R. C. Topiramate: clinical profile in epilepsy // Clin. Pharmacokinet. — 1998. — V. 34. — P. 335—346.
  38. Smith M., Wilcox K. S., White H. S. Discovery of antiepileptic drugs // Neurotherapeutics. — 2007. — V. 4. — P. 12—17.
  39. Stefan H., Feuerstein T. J. Novel anticonvulsant drugs // Pharmacol. Ther. — 2007. — V. 113. — P. 165—183.
  40. Veggiotti M., Ragnoli T. Topiramate and its possible advantages in pediatric practice // Pediat. Neonatol. — 2002. — V. 14. — P. 187—194.
  41. Walia K. S., Khaan E. A., Ko D. H. et al. Side effects of antiepileptics — a review // Pain Pract. — 2004. — V. 4. — P. 194—203.
  42. White H. S., Smith M. D., Wilcox K. S. Mechanisms of action of antiepileptic drugs // Int. Rev. Neurobiol. — 2007. — V. 81. — P. 85—110.

Journal’s Indexing:

UKRAINS'KYI VISNYK PSYKHONEVROLOHII

The Scientific and Practical Journal of Medicine

ДУ «ІНПН імені
П.В. ВОЛОШИНА
НАМН УКРАЇНИ»